In the last trading session, 51823.0 shares of the Athira Pharma Inc (NASDAQ:ATHA) were traded, and its beta was 3.00. Most recently the company’s share price was $0.28, and it changed around $0.01 or 2.03% from the last close, which brings the market valuation of the company to $10.78M. ATHA currently trades at a discount to its 52-week high of $3.67, offering almost -1210.71% off that amount. The share price’s 52-week low was $0.22, which indicates that the current value has risen by an impressive 21.43% since then.
Athira Pharma Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 3 recommended ATHA as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Athira Pharma Inc is expected to report earnings per share of 0 for the current quarter.
Athira Pharma Inc (NASDAQ:ATHA) trade information
Instantly ATHA has showed a green trend with a performance of 2.03% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.2890 on recent trading dayincreased the stock’s daily price by 3.11%. The company’s shares are currently down -52.96% year-to-date, but still up 1.47% over the last five days. On the other hand, Athira Pharma Inc (NASDAQ:ATHA) is -9.21% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $18, which translates to bulls needing to increase their stock price by 98.44% from its current value. Analyst projections state that ATHA is forecast to be at a low of $3 and a high of $33.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -73.94%. Athira Pharma Inc earnings are expected to increase by 75.66% in 2025, but the outlook is positive 62.77% per year for the next five years.
ATHA Dividends
Athira Pharma Inc’s next quarterly earnings report is expected to be released in June.
BAKER BROS. ADVISORS LP, with 8.2174% or 3.15 million shares worth $8.36 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 1.49 shares worth $0.41 million, making up 3.82% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 1.07 shares worth around $0.3 million, which represents about 2.75% of the total shares outstanding.
